MONDOBIOTECH HOLDING AG : (SIX:RARE) announces the exercise of the convertion rights by BioPharma Invest AG

January 25, 2013Stans, Switzerland

mondoBIOTECH holding AG ("mondoBIOTECH"), a Swiss-based drug discovery company focused on repurposing drugs in rare and neglected diseases and listed on the SIX Swiss Exchange (SIX: RARE), today announces that BioPharma Invest AG (BPI) has exercised its right to convert the CHF 2.5 million loan facility granted to the Company on 11th November 2011 into common shares of the Company.

The loan is to be converted into common shares at the average stock market price of the last 60 days prior to today's notice of conversion. The respective shares will have to be issued by the Company by way of a dedicated share capital increase.